New Anticoagulants for Stroke Prevention in Atrial Fibrillation
Published Online: Tuesday, January 14, 2014
Christian Ruff, MD, MPH, of Harvard Medical School, gives an overview of the anticoagulants currently available for prevention of stroke in patients with atrial fibrillation.
Digoxin increases risk of death in patients with newly diagnosed atrial fibrillation.
Researchers evaluated more than 2 decades of evidence on atrial fibrillation patients taking vitamin K antagonists.
Researchers evaluated the risk of cardiovascular outcomes in atrial fibrillation patients with a history of falls.